Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
BMC Med Genomics ; 16(1): 308, 2023 11 30.
Artigo em Inglês | MEDLINE | ID: mdl-38037065

RESUMO

BACKGROUND: Diminished ovarian reserve (DOR) is defined as a reduction in ovarian reserve and oocyte quality. The pathophysiology of DOR has not been completely explained as of yet. Scholars have uncovered a large number of exosomes that have been detected in follicular fluid, and exosomal miRNAs have been proven to play a critical role in controlling ovarian disorders and follicle formation. We focused on the expression profile of follicular fluid-derived exosomal microRNAs (miRNAs) and attempted to understand if their role is connected to the pathomechanism of DOR. METHODS: The follicular fluid-derived differentially expressed exosomal miRNAs (DEmiRs) between patients with DOR and those with normal ovarian function were investigated using the next-generation sequencing (NGS) method. The main metabolic and signaling pathways of DEmiRs were identified using the KEGG pathway database, disease ontology (DO) analysis, and gene ontology (GO) analysis. In the end, a Protein-Protein Interaction (PPI) network was built to search for exosomal miRNAs and their target genes that were potentially strongly connected with DOR. RESULTS: In comparison to normal controls, 52 DEmiRs were discovered in follicular fluid-derived exosomes of DOR patients, of which 19 were up-regulated and 33 were down-regulated (|log2(fold change) |>2, P < 0.05). GO, DO analysis, and the KEGG pathway database revealed that many of these DEmiRs have broad biological roles that are connected to ovarian function and disorders. The top ten DEmiRs in terms of expression were then chosen for miRNA-mRNA interaction analysis. Totally, 8 experimentally supported miRNAs (hsa-miR-1246, hsa-miR-483-3p, hsa-miR-122-5p, hsa-miR-130b-3p, hsa-miR-342-3p, hsa-miR-625-3p, hsa-miR-675-3p, and hsa-miR-134-5p) and 126 target genes were filtrated by utilizing Cytoscape software. The module analysis findings of the PPI network showed that the main module cluster with a score > 6.0 (MCODE score = 15) had six hub genes, including IGFR, VEGFA, KRAS, ERBB2, RHOA, and PTEN (MCODE score = 11.472). CONCLUSION: Our data suggested a special expression profile of follicular fluid-derived exosomal miRNAs in patients with DOR, which was probably correlated to ovarian dysfunction and follicle formation. These results may give a unique insight into a better understanding of the molecular process in the pathogenesis of DOR or other ovarian diseases.


Assuntos
MicroRNAs , Doenças Ovarianas , Reserva Ovariana , Feminino , Humanos , Líquido Folicular/metabolismo , MicroRNAs/genética , MicroRNAs/metabolismo , Transdução de Sinais/genética , Doenças Ovarianas/metabolismo
2.
Front Chem ; 7: 737, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31737609

RESUMO

The aim of this study is to investigate the transformation of hydrogen-donor solvent tetralin in the direct liquefaction process of coal. Pure tetralin liquid as well as mixture of tetralin and Wucaiwan coal (WCW) were separately reacted under a liquefaction condition, and constituents of liquid product were analyzed by GC-MS. The results show that after the tetralin liquid reacts with high-pressure hydrogen, 90% of the reaction product is in liquid state, the gaseous products mainly include alkane gas and COx gas. When the reaction temperatures were set at 380 and 420°C, respectively, the corresponding transformation rates of tetralin can be 34.72 and 52.74%. At 380°C, the tetralin mainly plays a role of passing active hydrogen, while at 420°C, it mainly occurs dehydrogenation transformation to provide active hydrogen, as well as generate naphthalene, methyl indan, and substituted benzene, etc. Taking tetralin as the hydrogen-donor solvent, the WCW was performed liquefaction reaction, and the obtained results show that the transformation rates of tetralin are 69.76 and 83.86% at liquefaction temperatures of 380 and 420°C, respectively. Tetralin mainly occur to dehydrogenation transformation to generate naphthalene, followed by methyl indan, where contents order of main constituents of the liquefaction products were: naphthalene> tetralin > methyl indan.

3.
In Vitro Cell Dev Biol Anim ; 51(2): 103-12, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25424832

RESUMO

Factors influencing porcine oocyte activation were systematically studied. This study included (1) the effect of ionomycin plus various chemical agents on activation, (2) comparison of different electrical activation parameters, (3) optimization of combined activation, and (4) evaluation of the optimized protocols. The results showed that (1) blastocyst rates of ionomycin (Ion) + 6-dimethylaminopurine (6-DMAP) (29.7 ± 1.1%), Ion + cytochalasin B (CB) + cycloheximide (CHX) (29.8 ± 1.2%), Ion + CB + 6-DMAP (30.4 ± 1.6%), and Ion + CB + CHX + 6-DMAP (30.2 ± 2.7%) were significantly higher than Ion + CHX (15.8 ± 1.5%, p < 0.05); (2) the parthenogenetic blastocyst formation of electrical activation was optimal when oocytes were activated by three direct current (DC) pulses of 1.00 kV cm(-1) for 80 µs (39.5 ± 1.1%); (3) blastocyst rates of DC + CB + CHX (55.4 ± 1.2%) and DC + CB + 6-DMAP (50.4 ± 2.9%) were significantly higher than DC + 6-DMAP, DC + CB + CHX + 6-DMAP, electrical activation, and chemical activation alone (p < 0.05); and (4) approximately 84% of parthenogenetic blastocysts yielded by the optimized protocol were diploid, which was significantly higher than that of electrical activation blastocysts (40%). Using the optimized electrical and combined activation protocol, high blastocyst rates were generated by intracytoplasmic sperm injection (ICSI) (34.6 ± 1.1%), cytoplasmic microinjection (CI) (52.3 ± 2.2%), and handmade cloning (HMC) (31.2 ± 1.0%), respectively. This study concludes that the optimal activation protocol of in vitro matured porcine oocytes was combined activation with parameter as three DC pulses of 1.00 kV cm(-1) for 80 µs plus CB and CHX treatment.


Assuntos
Blastocisto , Técnicas de Maturação in Vitro de Oócitos/métodos , Adenina/análogos & derivados , Adenina/farmacologia , Animais , Blastocisto/fisiologia , Cálcio/metabolismo , Cicloeximida/farmacologia , Diploide , Estimulação Elétrica , Feminino , Ionomicina/farmacologia , Masculino , Oócitos/efeitos dos fármacos , Oócitos/fisiologia , Partenogênese , Injeções de Esperma Intracitoplásmicas , Suínos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA